Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Calcitonin; related peptides
Patent
1992-11-30
1995-08-08
Warden, Jill
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
Calcitonin; related peptides
530324, A61K 3823
Patent
active
054400120
DESCRIPTION:
BRIEF SUMMARY
TECHNICAL FIELD
The present invention relates to a novel peptide and more paticularly to a calcitonin originating from the ultimobranchial glands of cartilaginous fishes. The invention also relates to a method for the preparation of the peptide and a pharmaceutical composition comprising the peptide as an active ingredient which is effective as a blood calcium-decreasing agent and a chondrocyte (cartilage cell) differentiation-promoting agent.
BACKGROUND ART
Calcitonin (abbreviated as CT) is a peptide hormone which participates in metabolism of minerals such as calcium and phosphorus and which is found in the thyroid glands of mammals and the ultimobranchial glands of birds and cartilaginous fishes.
The structures of calcitonins mainly originating from the thyroid glands of mammals have been identified for swine (Potts et al, Pro. Natl. Acad. Sci. USA 59: 1321-1328, 1968), humans (Neher et al, Nature 220: 984-996, 1968), bovines (Brewer et al, Biochemistry 63: 940-947, 1969), sheep (Potts et al, Calcium, Parathyroid Hormone and the Calcitonin: 121-127, 1972), and rats (Raulais et al, Eur. J. Biochem. 64: 607-611, 1976).
The structures of calcitonins mainly originating from the ultimobranchial glands have been identified for salmon (Niall et al, Pro. Natl. Acad. Sci. USA 64: 771-778, 1969), eels (Kotani et al, J. Biochem. 79: 345-352, 1976), and fowl (Homma et al, J. Biochem. 100: 459-467, 1986).
As shown in FIG. 1, the calcitonins which have heretofore been identified can be classified into three lineages: a swine lineage including swine, bovines, and sheep, a human lineage including humans and rats, and a salmon lineage including salmon, eels, and fowl. Each of these calcitonins is a single-chain polypeptide consisting of 32 amino acids in which the first and seventh amino acids are linked through a disulfide bond (S--S bond) to form a seven-membered ring with prolineamide present at the carboxyl terminus.
The above-described calcitonins are known to participate in the metabolic regulation of blood serum calcium and the bone metabolism. It has recently been found that, in addition to these activities, calcitonins also have an analgesic activity as a neurotransmitter and an antiulcer activity through calcium metabolism. However, the activities of calcitonins have not been elucidated completely. It is also known that the intensities of physiological activities of calcitonins greatly differ among the above-described lineages, e.g., in such a manner that those calcitonins originating from the ultimobranchial glands are much more potent than those calcitonins originating from the thyroid grands. For example, salmon calcitonin has an activity for decreasing the blood calcium level in humans which is about 30 times as high as that of human calcitonin.
Some calcitonins such as salmon and eel calcitonins or their derivatives have been commercially produced by means of chemical synthesis or genetic engineering, and they are available and used for treatment of osteoporosis and similar diseases. However, it is expected that these prior-art calcitonins lose their activities due to an increase in antibody level caused by long-term administration thereof. Accordingly, for therapeutic use of calcitonins, it is desired to find a novel calcitonin which does not belong to any of the above-described lineages of calcitonins. Such a novel calcitonin will be helpful in investigations to elucidate the physiological activities of calcitonins.
DISCLOSURE OF INVENTION
For the purpose of finding a novel calcitonin of a type which is different from known calcitonins, the inventors of the present invention focused on the ultimobranchial glands of cartilaginous fishes, which have not in the past been excised to isolate calcitonins. As described above, it is expected that a calcitonin originating from the ultimobranchial glands may have a strong physiological activity. As a result of investigations, it has been found that a blood calcium-decreasing factor having a strong activity is present in the ultimobranchial glands of cartil
REFERENCES:
patent: 4397780 (1983-08-01), Orlowski et al.
"Immunohistochemical Demonstration of Calcitonin Gene-Related Peptide in the Ultimobranchial Gland of Some Lower Vertebrates and in the Nervous Tissues of Some Invertebrates", Yuichi Sasayama et al., Zoological Science, vol. 6, pp. 423-426 (1989).
Y. Takei et al, Biol. Bull, 180, Jun. 1991, "New Calcitonin Isolated from the Ray, Dasyatis akajei," pp. 485-488.
Sasayama Yuichi
Takahashi Akiyoshi
Takei Yoshio
Takigawa Masaharu
Lukton David
Sumitomo Metal Industries Ltd.
Warden Jill
LandOfFree
Calcitonin and method for the preparation and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Calcitonin and method for the preparation and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Calcitonin and method for the preparation and use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-972251